Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol
- 8 July 2026
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- p. 1-10
Abstract
Cebranopadol is a first-in-class analgesic that combines agonism at the μ-opioid receptor (μOR) and the nociceptin/orphanin FQ receptor (NOPR), an approach proposed to improve the therapeutic index of opioid analgesia. Although Cebranopadol is highly potent at both μOR and NOPR, the structural basis by which a single small molecule productively engages these two opioid-family receptors has remained unclear. Here, we report cryo-electron microscopy structures of Cebranopadol bound to human μOR–Gi and NOPR–Gi complexes at 2.95 Å and 2.74 Å resolution, respectively. In both receptors, Cebranopadol adopts a conserved orthosteric recognition mode anchored by the canonical D3.32–tertiary amine interaction, whereas local differences in the extracellular pocket shift ligand position to accommodate receptor-specific microenvironments. Combined with functional mutagenesis and molecular dynamics simulations across the opioid receptor family, these structures identify nonconserved pocket features at positions 2.63 and 7.35 that contribute to potency and selectivity by modulating fluorophenyl-directed interactions and hydrophobic packing around the spiroindole moiety. Together, these findings define a structural framework for understanding the dual agonism of Cebranopadol at μOR and NOPR and provide a working model for improving selectivity over δOR and κOR while preserving the desired dual-target pharmacology.Keywords
This publication has 60 references indexed in Scilit:
- Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe PainJournal of Medicinal Chemistry, 2013
- A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with MorphineThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Structure of the δ-opioid receptor bound to naltrindoleNature, 2012
- Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimeticNature, 2012
- Crystal structure of the µ-opioid receptor bound to a morphinan antagonistNature, 2012
- Structure of the human κ-opioid receptor in complex with JDTicNature, 2012
- Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to humanBritish Journal of Pharmacology, 2011
- The Nociceptin/Orphanin FQ Receptor (NOP) as a Target for Drug Abuse MedicationsCurrent Topics in Medicinal Chemistry, 2011
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004